万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>全科医学与补充医学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>肿瘤学

INTEGRATIVE CANCER THERAPIES《癌症综合治疗》 (官网投稿)

简介
  • 期刊简称INTEGR CANCER THER
  • 参考译名《癌症综合治疗》
  • 核心类别 SCIE(2023版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率5.60%
  • 主要研究方向医学-INTEGRATIVE & COMPLEMENTARY MEDICINE全科医学与补充医学;ONCOLOGY肿瘤学

主要研究方向:

等待设置主要研究方向
医学-INTEGRATIVE & COMPLEMENTARY MEDICINE全科医学与补充医学;ONCOLOGY肿瘤学

INTEGRATIVE CANCER THERAPIES《癌症综合治疗》(年刊). Integrative Cancer Therapies focuses on a new and growing movement in cancer treatment. Integrativ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://journals.sagepub.com/home/ict

3、投稿网址:https://mc.manuscriptcentral.com/ict

4、官网邮箱:cgyllenhaal@blockmedical.com(编辑部)

5、官网电话:847-492-3040

6、期刊刊期:年刊,一年出版1期。

2021年1029日星期五

                          

 

投稿须知【官网信息】

 

Manuscript Submission Guidelines:

This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/ict to to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

Please also be sure to look over the submission checklist here before submitting.

Only manuscripts of sufficient quality that meet the aims and scope of Integrative Cancer Therapies will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal

Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:

SUBMIT MANUSCRIPT: https://mc.manuscriptcentral.com/ict

1. Open Access

Integrative Cancer Therapies is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

2. Article processing charge (APC)

If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.

The article processing charge (APC) for this journal is currently 2300 USD, payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

3. What do we publish?

3.1 Aims & scope

Before submitting your manuscript to Integrative Cancer Therapies, please ensure you have read the Aims & Scope.

3.2 Article types

Types of manuscripts accepted:

Research articles should contain the following sections: Introduction (with brief literature review), Methods, Results, Discussion, and Conclusions, and may be up to 35 double-spaced manuscript pages in length. Studies submitted should conscientiously adhere to ethical principles and practices, including informed consent in experiments involving human subjects, and humane practices in experiments on laboratory animals, and must mention obtaining ethical approval from the appropriate institutional board.

Brief reports on preliminary research projects, of up to 10 manuscript pages, are also welcomed.

Review papers should include scholarly considerations and clinical implications, and may be up to 65 double-spaced manuscript pages in length.

Case reports should explain the significance of the case, including relevant patient information, results of diagnostic tests, description of treatment and outcome, and may be up to 10 double-spaced manuscript pages in length.

Educational articles provide shorter summaries of the state of research or practice in a facet of integrative cancer treatment. They may be up to 45 double-spaced manuscript pages in length, should include a reference list, and should chiefly address the interests of practitioners.

Letters to the Editor: A letter to the Editor is a brief communication that either addresses the contents of a published article, or is a correspondence unrelated to a specific article. Its purpose is to make corrections, provide alternative viewpoints, or offer counter arguments. Avoid logical fallacies and ad hominem attacks. Letters to the Editor must be written in a professional tone and include references to support all claims if appropriate.

A letter to the Editor unrelated to a specific article should not exceed 500 words or have more than 3 references. A letter to the Editor pertaining to a recently published article or to be published concurrently with an article within the journal should not exceed 800 words or have more than 5 references. If an abstract is included, it will automatically be made the first paragraph. Letters should not include figures or research material. Letters to the editor are not charged an APC.

Commentaries are by invitation only. These are short summaries of significant recent and forthcoming papers, published elsewhere, that provide additional insights, new interpretations or speculation on the relevant topic. These manuscripts may include models, which due to space limitations were not included or discussed in the original paper. Commentaries may be written in free form, meaning that they do not need to be structured as a research paper, however it must include an abstract of 150-200 words. They should be between 1000-2000 words and have no more than 25 references. Please include keywords for indexing purposes. Figures are encouraged, but no more than three. Please give your commentary a brief title and add the phrase “Comment on (citation to your original article).” underneath the keywords. Commentary material may be peer reviewed at the editor’s discretion.

3.3 Writing your paper

The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

3.3.1 Making your article discoverable

When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

……

更多详情:

https://journals.sagepub.com/author-instructions/ICT


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭